PACS Group (NYSE:PACS) Releases Earnings Results, Beats Expectations By $0.05 EPS

PACS Group (NYSE:PACS) issued its quarterly earnings results on Tuesday. The company reported $0.63 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.58 by $0.05, FiscalAI reports. The firm had revenue of $1.50 billion during the quarter, compared to analyst estimates of $1.46 billion. PACS Group had a return on equity of 33.39% and a net margin of 4.87%.

PACS Group Stock Up 8.5%

NYSE:PACS opened at $50.63 on Thursday. PACS Group has a 1-year low of $10.31 and a 1-year high of $51.68. The company has a 50-day moving average of $44.42 and a 200 day moving average of $39.91. The firm has a market cap of $8.01 billion, a PE ratio of 21.32, a price-to-earnings-growth ratio of 1.46 and a beta of -0.14. The company has a debt-to-equity ratio of 0.21, a current ratio of 0.91 and a quick ratio of 0.91.

Analyst Ratings Changes

Several research firms recently commented on PACS. Truist Financial set a $62.00 price target on shares of PACS Group in a research note on Wednesday, September 2nd. JPMorgan Chase & Co. boosted their price objective on shares of PACS Group from $47.00 to $58.00 and gave the company an “overweight” rating in a research report on Friday, September 4th. Zacks Research downgraded shares of PACS Group from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, September 9th. Royal Bank Of Canada raised their target price on shares of PACS Group from $52.00 to $57.00 and gave the stock an “outperform” rating in a research report on Thursday, August 6th. Finally, Oppenheimer lifted their price target on shares of PACS Group from $48.00 to $57.00 and gave the company an “outperform” rating in a research note on Monday, August 10th. Five investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $58.80.

More PACS Group News

Here are the key news stories impacting PACS Group this week:

• Positive Sentiment: PACS reported third-quarter adjusted earnings of $0.63 per share, above estimates of $0.56–$0.58 and up from $0.32 a year earlier. Revenue of $1.50 billion beat the $1.46 billion forecast. PACS Group reports third-quarter results
• Positive Sentiment: The company raised its 2026 outlook to $5.95 billion–$6.05 billion in revenue and $685 million–$695 million in adjusted EBITDA. Its acquisitions in Florida and Texas add to its expansion plans, while leaders cited occupancy around 90%. PACS raises 2026 outlook PACS acquisitions and third-quarter results
• Negative Sentiment: CEO Jason Murray, director Mark Hancock and CAO Michelle Lewis disclosed stock sales. The transactions were made under pre-arranged Rule 10b5-1 plans, and the executives retain substantial holdings, which may temper—but does not eliminate—concern about insider selling. PACS insider transactions

Insider Activity

In other PACS Group news, CEO Jason Murray sold 167,434 shares of the firm’s stock in a transaction dated Wednesday, November 4th. The shares were sold at an average price of $50.24, for a total transaction of $8,411,884.16. Following the transaction, the chief executive officer owned 53,954,101 shares of the company’s stock, valued at approximately $2,710,654,034.24. This trade represents a 0.31% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Mark Hancock sold 186,696 shares of the company’s stock in a transaction that occurred on Wednesday, November 4th. The stock was sold at an average price of $50.45, for a total transaction of $9,418,813.20. Following the completion of the sale, the director directly owned 53,318,884 shares of the company’s stock, valued at $2,689,937,697.80. The trade was a 0.35% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 1,762,431 shares of company stock worth $80,686,053. 70.10% of the stock is owned by company insiders.

About PACS Group

PACS Group, Inc is a U.S.-based healthcare services company that owns and operates post-acute care facilities. Its platform focuses primarily on skilled nursing and transitional care, serving patients who require rehabilitation, recovery support, long-term care, and other services following hospitalization or acute medical treatment.

The company’s operations also include assisted living, independent living, and behavioral health services in select locations. Through its facilities and related healthcare capabilities, PACS Group provides services such as nursing care, physical and occupational therapy, speech therapy, medical treatment, and support for patients with complex or extended care needs.

Founded in 2013 and headquartered in Farmington, Utah, PACS Group serves communities across multiple U.S.